Pyoderma gangrenosum in a patient with chronic granulomatous disease A case report

被引：5

作者：

Nanoudis, Sideris ^{[1
]}

Tsona, Afroditi ^{[1
]}

Tsachouridou, Olga ^{[1
]}

Morfesis, Petros ^{[1
]}

Loli, Georgia ^{[1
]}

Georgiou, Adamantini ^{[1
]}

Zebekakis, Pantelis ^{[1
]}

Metallidis, Symeon ^{[1
]}

机构：

[1] Aristotle Univ Thessaloniki, AHEPA Univ Hosp, Dept Internal Med 1, 1 St Kyriakidi St, Thessaloniki 54636, Greece

来源：

MEDICINE | 2017年 / 96卷 / 31期

关键词：

Pyoderma gangrenosum; Chronic granulomatous disease; Primary immunodeficiency; NEUTROPHIL; DEFICIENCY; CHILD; IMMUNODEFICIENCY;

D O I：

10.1097/MD.0000000000007718

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Rationale: The simultaneous occurrence of pyoderma gangrenosum (PG) and chronic granulomatous disease (CGD) is uncommon and few cases have been reported worldwide. Patient concerns: PG is a rare, chronic, ulcerative, neutrophilic skin disease of unknown etiology that requires immunosuppressive treatment. CGD belongs to Primary Immune Deficiencies in which the main defect lies in an inability of the phagocytic cells to generate superoxide making patients susceptible to serious, potentially life-threatening bacterial and fungal infections. Diagnoses: In this manuscript, we present a case of ulcerative pyoderma gangrenosum in a 28-year-old man with recent diagnosis of chronic granulomatous disease during hospitalization for resistant pulmonary tuberculosis complicated with Aspergillus infection. Interventions: Second-line therapy with dapsone and intravenous immunoglobulin was initially administered but eventually corticosteroids were added to treatment because of disease progression and further ulceration. Outcomes: Patient's ulcers were gradually healed with no side effects. Lessons: Corticosteroids could be used under close monitoring for the treatment of PG in a patient with CGD, despite the increased risk for infections.

引用

页数：6

共 47 条

[1] Aberrant neutrophil trafficking and metabolic oscillations in severe pyoderma gangrenosum [J].